Investigation of potential adverse central nervous system effects after long term oral administration of gadolinium in mice.

Low levels of intracerebral Gd caused by chronic oral exposure over almost the entire life span of mice did not lead to alterations in locomotor abilities in healthy mice throughout the normal aging process.